Blood Tests for Talin-1 and Cripto-1 to Help Detect Colorectal Cancer
Measures Talin-1 and Cripto-1 in blood of adults with colorectal cancer and healthy people.
Plain-language title generated from the registry record
Registry title: Serum Talin-1 and Cripto-1 in Colorectal Cancer
Key facts
- Where
- Asyut, EgyptSee the site
Where in Egypt
- Assuit University HospitalAsyut, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assiut University
- Trial code
- NCT07414082
- Record updated
- 17 February 2026
- Original description
The goals of this study areRead full original descriptionShow less
Evaluating Serum Talin-1 and Cripto-1 as Diagnostic Biomarkers in Colorectal Cancer
The goals of this study are
* To evaluate the clinical utility of Talin-1 and Cripto-1 measurement in colorectal cancer patients in comparison with healthy controls. * To Compare the diagnostic significance of serum Talin-1 and Cripto-1 with traditional serum biomarker CEA
Inclusion: Age >18 years Old; Patients of both sexes who met the clinical diagnostic criteria of colorectal cancer (change in bowel habit, absolute or recurrent constipation, rectal bleeding, significant weight loss or intestinal obstruction); Patients diagnosed with colorectal cancer by imaging and histopathology.
Exclusion: Patients with past history of chemotherapy or surgical excision of tumor; Patients with hereditary non-polyposis colorectal cancer; Patients with inflammatory bowel disease; Age <18 years old; Patients with familial adenomatous polyposis; patients with other types of tumors.